GLP-3RT 12MG
$110.00
GLP-3RT is a high-purity triple-agonist peptide used in professional research exploring metabolic regulation, multi-hormonal signaling, and advanced incretin pathway models. Its combined GLP-1, GIP, and glucagon receptor activity makes it a valuable tool for studying energy balance, glucose pathways, and next-generation metabolic mechanisms.
-
Supports studies on GLP-1 / GIP / glucagon triple-agonist activity
-
Ideal for metabolic, energy balance, and glucose-response research
-
Suitable for modeling next-generation incretin-based compounds
In stock
Volume Discounts
Bulk Volume Discounts starting as low as 20 units per Product
Custom Labeling
3 Tiers of labeling: Unlabeled, Generic, and Custom Label
Quality Guarantee
All products come with a 30-Day Quality Guarantee.
US-Based Support
US-based support available Monday - Friday 7-6pm ET
Description
Also Known As: LY3437943
CAS Number: 2381089-83-2
Molecular Formula: C187H291N51O60
Molecular Weight: ~4260 g/mol
Form: Lyophilized Powder
Quantity: 12MG Per Vial
Purity: ≥ 98% (HPLC Verified)
Product Overview
GLP-3RT is an investigational triple-agonist peptide that simultaneously targets GLP-1, GIP, and glucagon receptors, offering a multi-pathway model for advanced metabolic research. Its unique receptor activity makes it a valuable tool for examining combined incretin signaling, energy regulation, lipid metabolism, and glucose-related pathways.
In professional research environments, GLP-3RT is increasingly studied for its broad metabolic impact and its potential to outperform single or dual agonists in multi-hormonal investigations.
Researchers commonly use GLP-3RT in:
-
Obesity and weight-related research models
-
Studies involving glucose regulation and insulin pathway analysis
-
Investigations into lipid metabolism and energy expenditure
-
Explorations of multi-hormone metabolic mechanisms
Intended Applications
-
Comparative studies evaluating GLP-1/GIP/glucagon receptor synergy
-
Research into body composition, energy balance, and metabolic output
-
Studies focused on glycemic control and insulin response indicators
-
Preclinical modeling of next-generation incretin-based compounds
Selected Published Clinical Data (For Scientific Context Only)
Included for informational reference and not indicative of product use.
-
GLP-3RT: Triple–Hormone-Receptor Agonist for Obesity — Phase 2 Trial
-
GLP-3RT Study (LY3437943) in Participants With Obesity & Cardiovascular Conditions (TRIUMPH-3)
-
GLP-3RT: Triple-Agonist Evaluation for Obesity — Phase 2 Trial
Storage & Handling
-
Store lyophilized material at –20°C, protected from moisture and light.
-
Reconstitute using bacteriostatic water under sterile laboratory technique.
-
After reconstitution, refrigerate at 2–8°C and use within appropriate professional timelines.
-
Avoid repeated freeze–thaw cycles.
Professional Use Only - Legal Disclaimer
All PeptiMed products are classified as Professional Use Only (PUO) and are intended exclusively for qualified professionals, licensed facilities, and authorized organizations. These products are not approved by the FDA and are not intended for personal use, consumer use, or unsupervised application.
By purchasing or using PeptiMed products, you confirm that you are a properly licensed professional acting within the scope of your credentials and that you understand all regulatory, safety, and compliance obligations associated with handling these materials. Products must not be sold, supplied, or provided directly to consumers or used outside an appropriate professional environment.
All handling, storage, and use of PeptiMed products are undertaken at your own risk. PeptiMed assumes no responsibility for misuse, improper application, or any clinical, regulatory, or professional consequences resulting from their use.
Labeling Options
All labeled vials include product details and batch information including a QR Code* to the COA printed on each label
Custom White-Label
Generic Label
Unlabeled Vial
*QR Codes coming in early 2026